Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
25 07 2023
Historique:
received: 17 06 2023
revised: 14 07 2023
accepted: 18 07 2023
medline: 14 8 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: epublish

Résumé

Phytocannabinoids, including the non-addictive cannabis component cannabidivarin (CBDV), have been reported to hold therapeutic potential in several neurodevelopmental disorders (NDDs). Nonetheless, the therapeutic value of phytocannabinoids for treating Fragile X syndrome (FXS), a major NDD, remains unexplored. Here, we characterized the neurobehavioral effects of CBDV at doses of 20 or 100 mg/kg in the

Identifiants

pubmed: 37566006
pii: cells12151927
doi: 10.3390/cells12151927
pmc: PMC10416983
pii:
doi:

Substances chimiques

cannabidivarin I198VBV98I
Fragile X Mental Retardation Protein 139135-51-6
Fmr1 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2022 May 4;12(1):7269
pubmed: 35508566
J Autism Dev Disord. 2013 Jun;43(6):1452-8
pubmed: 23015112
Behav Brain Res. 2006 Mar 15;168(1):172-5
pubmed: 16343653
Autism Res. 2017 Jun;10(6):1067-1078
pubmed: 28301083
Int J Biochem Cell Biol. 2014 Aug;53:121-6
pubmed: 24831882
Neurobiol Dis. 2009 Nov;36(2):361-73
pubmed: 19666116
Exp Cell Res. 2000 Jul 10;258(1):162-70
pubmed: 10912798
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Dev Neurosci. 2011;33(5):395-403
pubmed: 22067669
Neuron. 2012 Apr 12;74(1):49-56
pubmed: 22500629
Psychoneuroendocrinology. 2006 Jul;31(6):781-5
pubmed: 16621323
Front Cell Neurosci. 2022 Oct 27;16:917183
pubmed: 36385949
J Neurosci. 2010 Jan 13;30(2):694-702
pubmed: 20071534
Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
pubmed: 10817843
Psychoneuroendocrinology. 2014 Nov;49:119-29
pubmed: 25080404
Behav Brain Res. 2010 Mar 17;208(1):96-105
pubmed: 19932134
Nat Med. 2017 Jun;23(6):674-677
pubmed: 28504725
Dev Psychobiol. 1983 Mar;16(2):83-109
pubmed: 6339302
Genes Brain Behav. 2012 Apr;11(3):332-41
pubmed: 22268788
Neuropsychopharmacology. 2008 Oct;33(11):2667-75
pubmed: 18172434
Int J Neuropsychopharmacol. 2011 Jun;14(5):618-30
pubmed: 20497624
Science. 2007 May 25;316(5828):1212-6
pubmed: 17525344
Psychopharmacology (Berl). 2014 Aug;231(15):3009-17
pubmed: 24577515
J Cell Biol. 2003 Nov 10;163(3):463-8
pubmed: 14610053
Psychopharmacology (Berl). 2012 Feb;219(3):859-73
pubmed: 21796370
Neuroscience. 2011 Oct 27;194:282-90
pubmed: 21723920
Bioorg Med Chem. 2015 Apr 1;23(7):1377-85
pubmed: 25703248
Neuron. 2012 Oct 18;76(2):325-37
pubmed: 23083736
Behav Brain Res. 2017 Mar 1;320:128-135
pubmed: 27939692
Genes Brain Behav. 2005 Oct;4(7):420-30
pubmed: 16176388
J Neurosci. 1995 Mar;15(3 Pt 1):1768-77
pubmed: 7891134
Exp Neurol. 2010 Jul;224(1):3-14
pubmed: 20353783
Cell. 1991 Aug 23;66(4):817-22
pubmed: 1878973
J Neurodev Disord. 2017 Jun 12;9:6
pubmed: 28616095
Oncotarget. 2014 Aug 15;5(15):5852-72
pubmed: 25115386
Vitam Horm. 2010;82:185-200
pubmed: 20472139
Prog Chem Org Nat Prod. 2017;103:103-131
pubmed: 28120232
Pharmacotherapy. 2016 Jul;36(7):781-96
pubmed: 27285147
Neurotherapeutics. 2015 Oct;12(4):825-36
pubmed: 26341731
J Neurochem. 2008 Aug;106(3):1378-87
pubmed: 18485098
Physiol Rev. 2009 Jan;89(1):309-80
pubmed: 19126760
Behav Brain Res. 2012 Mar 1;228(1):1-8
pubmed: 22123412
Behav Brain Res. 2012 Apr 1;229(1):244-9
pubmed: 22285772
J Mol Neurosci. 2000 Oct;15(2):99-108
pubmed: 11220789
PLoS One. 2010 Mar 16;5(3):e9706
pubmed: 20300527
Neuroscience. 2013 Jun 3;239:196-213
pubmed: 22967840
Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11489-94
pubmed: 17592139
Neurobiol Aging. 2013 Jun;34(6):1599-609
pubmed: 23352115
Behav Brain Res. 1996 Jun;78(1):25-36
pubmed: 8793034
Pharmacol Biochem Behav. 2006 Dec;85(4):842-9
pubmed: 17204313
Neurosci Biobehav Rev. 2022 Aug;139:104722
pubmed: 35690123
Hum Mol Genet. 2000 May 1;9(8):1145-59
pubmed: 10767339
Trends Neurosci. 2004 Jul;27(7):370-7
pubmed: 15219735
Anim Behav. 2000 Nov;60(5):689-694
pubmed: 11082239
Elife. 2022 Oct 11;11:
pubmed: 36217821
Stress. 2000 May;3(3):201-8
pubmed: 10938581
Neuropharmacology. 2018 Sep 15;140:121-129
pubmed: 30056123
Front Cell Neurosci. 2019 Aug 09;13:367
pubmed: 31447649
J Neurosci. 2007 Dec 19;27(51):13958-67
pubmed: 18094233
Hippocampus. 2002;12(1):39-46
pubmed: 11918286
Brain Res. 2002 Feb 8;927(1):8-17
pubmed: 11814427
Behav Genet. 2009 Nov;39(6):623-31
pubmed: 19641985
Biochem Cell Biol. 1999;77(4):331-42
pubmed: 10546896
Autism Res. 2017 Oct;10(10):1584-1596
pubmed: 28590057
Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):1106-15
pubmed: 17976923
Nat Neurosci. 2009 Sep;12(9):1152-8
pubmed: 19648913
Neuron. 2006 Aug 17;51(4):455-66
pubmed: 16908411
Brain Res. 2012 Feb 23;1439:7-14
pubmed: 22265702
Nat Neurosci. 2014 Dec;17(12):1701-9
pubmed: 25383903
Neuropsychopharmacology. 2015 Mar 13;40(5):1113-22
pubmed: 25348604
Nat Rev Neurosci. 2008 Jan;9(1):46-56
pubmed: 18073775
Ann N Y Acad Sci. 2004 Jun;1021:23-6
pubmed: 15251870
Br J Pharmacol. 2012 Dec;167(8):1629-42
pubmed: 22970845
Behav Brain Res. 2019 Oct 17;372:112068
pubmed: 31271818
Cell. 1994 Jul 15;78(1):23-33
pubmed: 8033209
Pharmacol Ther. 2012 Jan;133(1):79-97
pubmed: 21924288
Neuropsychopharmacology. 2010 Jun;35(7):1500-9
pubmed: 20393458
Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3254-63
pubmed: 23108544
Pharmacol Res. 2016 Oct;112:119-127
pubmed: 26845349
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11557-62
pubmed: 16076950
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Handb Exp Pharmacol. 2005;(168):299-325
pubmed: 16596779
Pharmacol Rep. 2013;65(3):535-46
pubmed: 23950576
Biol Psychiatry. 2014 Feb 1;75(3):189-97
pubmed: 23910948
Orphanet J Rare Dis. 2014 Aug 01;9:124
pubmed: 25079250
Neuropsychopharmacology. 2009 Mar;34(4):1011-26
pubmed: 18843266
J Psychopharmacol. 2019 Jul;33(7):894-907
pubmed: 31084246
Genes Brain Behav. 2012 Jul;11(5):513-23
pubmed: 22435671
PLoS One. 2011 Feb 22;6(2):e17073
pubmed: 21364941
J Neurosci. 2010 Apr 21;30(16):5724-9
pubmed: 20410124
Autism Res. 2011 Feb;4(1):40-56
pubmed: 21268289
Front Neurosci. 2022 Jul 08;16:968115
pubmed: 35879927
Behav Pharmacol. 2004 Sep;15(5-6):433-42
pubmed: 15343070
Front Mol Neurosci. 2015 Nov 16;8:68
pubmed: 26635521
Cell. 1991 May 31;65(5):905-14
pubmed: 1710175
Mini Rev Med Chem. 2009 Apr;9(4):448-62
pubmed: 19356123
Nat Commun. 2012;3:1080
pubmed: 23011134
J Neurosci. 2001 Dec 15;21(24):RC188
pubmed: 11734603
Nat Med. 2013 May;19(5):603-7
pubmed: 23542787
Behav Brain Res. 2011 Oct 1;223(2):310-21
pubmed: 21571007

Auteurs

Marika Premoli (M)

CNRS, EPHE, INCIA, UMR 5287, Univ. Bordeaux, 33000 Bordeaux, France.
Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.

William Fyke (W)

CNRS, EPHE, INCIA, UMR 5287, Univ. Bordeaux, 33000 Bordeaux, France.
Graduate Program in Neural and Behavioral Science, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.

Luigi Bellocchio (L)

INSERM, U1215 NeuroCentre Magendie, Group Endocannabinoids and Neuroadaptation, University of Bordeaux, 33077 Bordeaux, France.

Valerie Lemaire (V)

CNRS, EPHE, INCIA, UMR 5287, Univ. Bordeaux, 33000 Bordeaux, France.

Marie Wolley-Roberts (M)

Jazz Pharmaceuticals, Inc., Cambridge OX4 2RW, UK.

Bruno Bontempi (B)

CNRS, EPHE, INCIA, UMR 5287, Univ. Bordeaux, 33000 Bordeaux, France.

Susanna Pietropaolo (S)

CNRS, EPHE, INCIA, UMR 5287, Univ. Bordeaux, 33000 Bordeaux, France.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH